Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMC 1774876)

Published in Gut on April 21, 2005

Authors

C Durno1, M Aronson, B Bapat, Z Cohen, S Gallinger

Author Affiliations

1: Division of Gastroenterology and Clinical Nutrition, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, 555 University Ave, Toronto, Ontario, Canada M5G 1X8. carol.durno@sickkids.ca

Articles citing this

Letter to the editor: rectal cancer in a 15-year-old female with a novel MLH1 and MSH6 biallelic inheritance. Int J Colorectal Dis (2014) 1.39

Unique characteristics of adolescent and young adult acute lymphoblastic leukemia, breast cancer, and colon cancer. J Natl Cancer Inst (2011) 1.18

Colonic polyps in children and adolescents. Can J Gastroenterol (2007) 1.12

MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer. Clin Cancer Res (2010) 1.01

Higher occurrence of childhood cancer in families with germline mutations in BRCA2, MMR and CDKN2A genes. Fam Cancer (2008) 1.00

Early-onset colorectal cancer: a separate subset of colorectal cancer. World J Gastroenterol (2014) 0.88

White blood cell count and the risk of colon cancer. Yonsei Med J (2006) 0.87

Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis. Fam Cancer (2010) 0.86

Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma. Cancer (2016) 0.85

Colon carcinoma in childhood: review of the literature with four case reports. Int J Colorectal Dis (2012) 0.81

Mismatch repair protein expression in colorectal cancer. J Gastrointest Oncol (2013) 0.79

Syndrome-Associated Tumors by Organ System. J Pediatr Genet (2016) 0.75

PMS2 mutations in childhood cancer. Gut (2005) 0.75

Fifteen-year-old colon cancer patient with a 10-year history of ulcerative colitis. World J Gastroenterol (2013) 0.75

Truncation of the MSH2 C-terminal 60 amino acids disrupts effective DNA mismatch repair and is causative for Lynch syndrome. Fam Cancer (2016) 0.75

Colorectal carcinoma in first decade of life: our experience. Pediatr Surg Int (2014) 0.75

Colorectal carcinoma in the first decade of life: a systematic review. Int J Colorectal Dis (2015) 0.75

Articles cited by this

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res (1998) 20.08

New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology (1999) 11.94

Identification of FAP locus genes from chromosome 5q21. Science (1991) 11.41

Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med (2000) 8.68

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology (2000) 8.41

Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors. Nat Genet (2002) 7.00

Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer (1999) 6.73

The molecular basis of Turcot's syndrome. N Engl J Med (1995) 6.65

Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening. Can J Gastroenterol (2004) 5.09

Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology (1997) 3.97

Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology (1996) 3.54

AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology (2001) 2.63

Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol (1999) 1.85

Colorectal carcinoma in children and adolescents--a report of seven cases. Eur J Pediatr Surg (2001) 1.64

Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res (1999) 1.62

Hereditary nonpolyposis colorectal cancer in young colorectal cancer patients: high-risk clinic versus population-based registry. Gastroenterology (2002) 1.16

Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer. Hum Genet (1999) 1.10

Alimentary tract malignancies in children. J Pediatr Surg (1997) 1.07

Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology (2004) 1.05

Colorectal cancer in the young: a 12-year review of patients 30 years or less. Colorectal Dis (2004) 0.95

Cancer of the colon and rectum in the first three decades of life. Hepatogastroenterology (1997) 0.87

Clinical management and genetics of gastrointestinal polyps in children. J Pediatr Gastroenterol Nutr (2000) 0.85

Colorectal cancer in adolescents. Ann R Coll Surg Engl (1999) 0.82

Microsatellite instability and p53 mutations in pediatric secondary malignant neoplasms. Cancer (1999) 0.82

Colorectal carcinoma in the first three decades of life. Am J Surg Pathol (1979) 0.81

Family history of cancer in children and young adults with colorectal cancer. Med Pediatr Oncol (1999) 0.80

Articles by these authors

Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet (2001) 11.12

Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med (2000) 8.68

The molecular basis of Turcot's syndrome. N Engl J Med (1995) 6.65

MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell (1996) 4.13

Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-D-mannopyranoside. J Infect Dis (1979) 3.82

Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet (2000) 3.52

Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology (1988) 3.40

Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet (2004) 2.95

Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol (1989) 2.49

MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet (1995) 2.49

Cancer in an ileoanal reservoir: a new late complication? Gut (1990) 2.41

Identification of an altered splice site in Ashkenazi Tay-Sachs disease. Nature (1988) 2.23

NEW ANTIGENIC COMPONENT OF PASTEURELLA PESTIS FORMED UNDER SPECIFIED CONDITIONS OF pH AND TEMPERATURE. J Bacteriol (1961) 2.13

Human microphthalmia associated with mutations in the retinal homeobox gene CHX10. Nat Genet (2000) 2.13

Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet (1998) 2.12

Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene (1999) 2.10

Single-patient randomised clinical trial. Use in determining optimum treatment for patient with inflammation of Kock continent ileostomy reservoir. Lancet (1986) 2.06

Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study. Am J Pathol (1999) 2.02

An unusual intraoperative complication of stapled colorectal anastomosis: report of a case and review of the literature. Can J Surg (1993) 2.00

Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma. Nature (2000) 1.93

Restorative proctocolectomy with ileal reservoir. Int J Colorectal Dis (1986) 1.91

Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology (1995) 1.90

Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol (1999) 1.85

Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res (1994) 1.85

Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum (1996) 1.82

Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Res (2000) 1.81

Somatic instability of the APC I1307K allele in colorectal neoplasia. Cancer Res (1998) 1.79

Molecular biology of colorectal cancer. Curr Probl Cancer (1998) 1.70

Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res (1995) 1.69

Prospective evaluation of early morphological changes in pelvic ileal pouches. Gastroenterology (1994) 1.66

The ileal reservoir and ileoanal anastomosis procedure. Factors affecting technical and functional outcome. Dis Colon Rectum (1988) 1.64

Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res (1999) 1.62

COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62

Characterization of the human HEXB gene encoding lysosomal beta-hexosaminidase. Genomics (1988) 1.60

Revising the troublesome stoma: combined abdominal wall recontouring and revision of stomas. Dis Colon Rectum (2003) 1.58

Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res (2000) 1.57

Quality of life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology (1991) 1.57

Serum vitamin B12 levels and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc (1994) 1.57

Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice. Cancer Res (2000) 1.56

Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet (1997) 1.55

Ontario familial colon cancer registry: methods and first-year response rates. Chronic Dis Can (2000) 1.55

Population shift in mannose-specific fimbriated phase of Klebsiella pneumoniae during experimental urinary tract infection in mice. Infect Immun (1985) 1.55

Can the standard gamble be used to determine utilities for uncertain health states? An example using postoperative maintenance therapy in Crohn's disease. Med Decis Making (2000) 1.51

Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol (2003) 1.51

Pregnancy, delivery, and pouch function after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum (2002) 1.50

Functional outcome of conversion of ileorectal anastomosis to ileal pouch-anal anastomosis in patients with familial adenomatous polyposis and ulcerative colitis. Dis Colon Rectum (1999) 1.49

The pelvic pouch and ileoanal anastomosis procedure. Surgical technique and initial results. Am J Surg (1985) 1.47

Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum (2000) 1.47

Complications of loop ileostomy. Am J Surg (1987) 1.43

Radioimmunodetection of colorectal cancer metastases with 131I-labeled monoclonal antibody B72.3: a pilot study to determine efficacy of detection and pharmacokinetics. Cancer Invest (1993) 1.42

MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res (1996) 1.41

Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies. Fam Cancer (2007) 1.39

Unusual presentation of omphalomesenteric duct remnant: a variant of mesodiverticular band causing intestinal obstruction. J Pediatr Surg (2000) 1.39

Anal wall thickness under normal and inflammatory conditions of the anorectum as determined by endoluminal ultrasonography. Am J Gastroenterol (1995) 1.38

Double stapling technique for low anterior resection. Dis Colon Rectum (1983) 1.38

Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol (2011) 1.36

Hospital procedure volume and teaching status do not influence treatment and outcome measures of rectal cancer surgery in a large general population. J Gastrointest Surg (2000) 1.35

Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2012) 1.35

Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation. Oncogene (2004) 1.35

Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. Cancer Res (1996) 1.34

High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1. J Immunol Methods (1994) 1.32

Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl (2000) 1.32

Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16. Gastroenterology (1998) 1.32

Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.29

Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions. Clin Pharmacokinet (1995) 1.29

Reevaluation of nitrate and nitrite levels in the human intestine. Cancer Res (1981) 1.27

The double stapling technique for low anterior resection of rectal carcinoma. Dis Colon Rectum (1986) 1.27

Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet (1999) 1.26

Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Clin Genet (2007) 1.25

Risk factors for pelvic pouch failure. Dis Colon Rectum (1997) 1.25

Rare spontaneous regression of patent omphalomesenteric duct after birth. Arch Dis Child Fetal Neonatal Ed (2002) 1.23

Sequential study of bacterial clearance in experimental cystitis. J Med Microbiol (1984) 1.23

The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease. Gut (2010) 1.23

Motivations and psychosocial impact of genetic testing for HNPCC. Am J Med Genet (2001) 1.20

Treatment of rectovaginal fistulas that has failed previous repair attempts. Dis Colon Rectum (1995) 1.18

Risk factors in elective laparoscopic cholecystectomy for conversion to open cholecystectomy. J Am Coll Surg (1994) 1.18

A cyclophilin-related protein involved in the function of natural killer cells. Proc Natl Acad Sci U S A (1993) 1.17

Preduodenal portal vein causing duodenal obstruction associated with situs inversus, intestinal malrotation, and polysplenia: A case report. J Pediatr Surg (2002) 1.17

Effect of mucous glycoprotein on nucleation time of human bile. Gastroenterology (1985) 1.16

Formation of histiocyte rings in response to Cryptococcus neoformans infection. J Reticuloendothel Soc (1965) 1.16

Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol (1998) 1.16

Canine small bowel transplantation. A study of the immunological responses. Arch Surg (1976) 1.16

STK11/LKB1 germline mutations are not identified in most Peutz-Jeghers syndrome patients. Clin Genet (1999) 1.13

Microsatellite instability, mismatch repair deficiency, and colorectal cancer. Surgery (2001) 1.13

Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. J Immunol (1994) 1.13